U.S. POC/Decentralized Diagnostic Testing Market 2016: Supplier Shares, Volume and Sales Forecasts for 300 Tests, Emerging Technologies, Competitive Strategies

Nov 20, 2015, 17:10 ET from Research and Markets

$codeDebug.log("output array of get country targets countryT

DUBLIN, Nov. 20, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/kp2tnc/2016_u_s) has announced the addition of the "2016 U.S. POC/Decentralized Diagnostic Testing Market: Supplier Shares, Volume and Sales Forecasts for 300 Tests, Emerging Technologies, Competitive Strategies" report to their offering.

This new 1,172-page report contains 256 tables, and provides a comprehensive analysis of the10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

- Review of the10 major POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.

Five-year test volume and reagent sales forecasts for over 300 chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment:

- Home/Personal Testing - Physician Offices/Group Practices - Emergency Rooms - Operating/Recovery Suites - ICUs/CCUs - Cancer Clinics - Ambulatory Care Centers - Surgery Centers - Nursing Homes - Birth Centers

By test category:

- Routine and Special Chemistry - Microbiology/Infectious Diseases - Hematology - Flow Cytometry - Coagulation - Immunoproteins - Drugs of Abuse - TDM - Endocrine Function - Tumor Markers

Competitive Assessments

- Abbott- ADI/American Diagnostica/Sekisui- Agilent Technologies- Alere/Biosite/Inverness- Axis-Shield- Beckman Coulter/Danaher- Becton Dickinson- Bio/Data- Biomerieux- Bio-Rad- Cepheid- Diamedix- Diasorin- Eiken Chemical- EKF Diagnostics- Fujirebio- Grifols- Helena Laboratories- Horiba- Instrumentation Laboratory- Kreatech/Leica- Kyowa Medex- Lonza- Mackay Life Sciences- Matritech- Nihon Kohden- Polartechnics- Polymedco- Qiagen- Roche- Tosoh- Wako- Zycare/Alere

For more information visit http://www.researchandmarkets.com/research/kp2tnc/2016_u_s

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com